Form 8-K - Current report:
SEC Accession No. 0001683168-24-008712
Filing Date
2024-12-13
Accepted
2024-12-13 16:30:20
Documents
14
Period of Report
2024-12-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT xenetic_8k.htm   iXBRL 8-K 38415
  Complete submission text file 0001683168-24-008712.txt   237213

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE xbio-20241211.xsd EX-101.SCH 3079
3 XBRL LABEL FILE xbio-20241211_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE xbio-20241211_pre.xml EX-101.PRE 22363
5 XBRL DEFINITION FILE xbio-20241211_def.xml EX-101.DEF 26184
16 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 3572
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 241548840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)